Literature DB >> 20704767

Sleep in psychiatric disorders: where are we now?

Elliott Kyung Lee1, Alan B Douglass.   

Abstract

Although the precise function of sleep is unknown, decades of research strongly implicate that sleep has a vital role in central nervous system (CNS) restoration, memory consolidation, and affect regulation. Slow-wave sleep (SWS) and rapid eye movement (REM) sleep have been of significant interest to psychiatrists; SWS because of its putative role in CNS energy recuperation and cognitive function, and REM sleep because of its suggested involvement in memory, mood regulation, and possible emotional adaptation. With the advent of the polysomnogram, researchers are now beginning to understand some of the consequences of disrupted sleep and sleep deprivation in psychiatric disorders. The same neurochemistry that controls the sleep-wake cycle has also been implicated in the pathophysiology of numerous psychiatric disorders. Thus it is no surprise that several psychiatric disorders have prominent sleep symptoms. This review will summarize normal sleep architecture, and then examine sleep abnormalities and comorbid sleep disorders seen in schizophrenia, as well as anxiety, cognitive, and substance abuse disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20704767     DOI: 10.1177/070674371005500703

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  17 in total

1.  Next-generation psychiatric assessment: Using smartphone sensors to monitor behavior and mental health.

Authors:  Dror Ben-Zeev; Emily A Scherer; Rui Wang; Haiyi Xie; Andrew T Campbell
Journal:  Psychiatr Rehabil J       Date:  2015-04-06

Review 2.  Sleep, slow-wave sleep, and blood pressure.

Authors:  Sogol Javaheri; Susan Redline
Journal:  Curr Hypertens Rep       Date:  2012-10       Impact factor: 5.369

3.  Perceived sleep quality is worse than objective parameters of sleep in pregnant women with a mental disorder.

Authors:  Leontien M Van Ravesteyn; Joke H M Tulen; Astrid M Kamperman; Monique E Raats; A J Tom Schneider; Erwin Birnie; Eric A P Steegers; Witte J G Hoogendijk; Henning W Tiemeier; Mijke P Lambregtse-van den Berg
Journal:  J Clin Sleep Med       Date:  2014-10-15       Impact factor: 4.062

4.  [The contributions by Emil Kraepelin to the knowledge on sleep disorders and their treatment].

Authors:  K Becker; M Kluge; H Steinberg
Journal:  Nervenarzt       Date:  2015-11       Impact factor: 1.214

5.  Altered sleep and affect in the neurotensin receptor 1 knockout mouse.

Authors:  Karrie Fitzpatrick; Christopher J Winrow; Anthony L Gotter; Joshua Millstein; Janna Arbuzova; Joseph Brunner; Andrew Kasarskis; Martha H Vitaterna; John J Renger; Fred W Turek
Journal:  Sleep       Date:  2012-07-01       Impact factor: 5.849

6.  Effects of stressor controllability on diurnal physiological rhythms.

Authors:  Robert S Thompson; John P Christianson; Thomas M Maslanik; Steve F Maier; Benjamin N Greenwood; Monika Fleshner
Journal:  Physiol Behav       Date:  2013-02-27

7.  Wheel running improves REM sleep and attenuates stress-induced flattening of diurnal rhythms in F344 rats.

Authors:  Robert S Thompson; Rachel Roller; Benjamin N Greenwood; Monika Fleshner
Journal:  Stress       Date:  2016-04-28       Impact factor: 3.493

8.  Effects of sleep deprivation on central auditory processing.

Authors:  Paulo Breno Noronha Liberalesso; Karlin Fabianne Klagenberg D'Andrea; Mara L Cordeiro; Bianca Simone Zeigelboim; Jair Mendes Marques; Ari Leon Jurkiewicz
Journal:  BMC Neurosci       Date:  2012-07-23       Impact factor: 3.288

9.  The circadian clock gene Csnk1e regulates rapid eye movement sleep amount, and nonrapid eye movement sleep architecture in mice.

Authors:  Lili Zhou; Camron D Bryant; Andrew Loudon; Abraham A Palmer; Martha Hotz Vitaterna; Fred W Turek
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

10.  Improvement of circadian rhythm of heart rate variability by eurythmy therapy training.

Authors:  Georg Seifert; Jenny-Lena Kanitz; Kim Pretzer; Günter Henze; Katharina Witt; Sina Reulecke; Andreas Voss
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-05       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.